StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Vireo Growth revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Vireo Growth's revenue for the twelve months ending Jun 30, 2026 was $511.67M, up 316.7% year over year. For fiscal 2025 it was $268.77M, up 170.4% from the year before. The highest annual figure on record is $268.77M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$268.77M+170.4%
FY2024Dec 31, 2024$99.38M+12.8%
FY2023Dec 31, 2023$88.13M+18.1%
FY2022Dec 31, 2022$74.63M+37.1%
FY2021Dec 31, 2021$54.45M+10.6%
FY2020Dec 31, 2020$49.21M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$209.30M+335.1%
Q1 FY2026Mar 31, 2026$106.20M+333.5%
Q4 FY2025Dec 31, 2025$104.51M+317.7%
Q3 FY2025Sep 30, 2025$91.66M+264.2%
Q2 FY2025Jun 30, 2025$48.10M+91.6%
Q1 FY2025Mar 31, 2025$24.50M+1.7%
Q4 FY2024Dec 31, 2024$25.02M+3.5%
Q3 FY2024Sep 30, 2024$25.17M+2.0%
Q2 FY2024Jun 30, 2024$25.11M+24.3%
Q1 FY2024Mar 31, 2024$24.09M+26.2%
Q4 FY2023Dec 31, 2023$24.17M+26.9%
Q3 FY2023Sep 30, 2023$24.68M+30.9%
Q2 FY2023Jun 30, 2023$20.20M-4.2%
Q1 FY2023Mar 31, 2023$19.09M+22.1%
Q4 FY2022Dec 31, 2022$19.04M+39.4%
Q3 FY2022Sep 30, 2022$18.85M+41.0%
Q2 FY2022Jun 30, 2022$21.09M+48.2%
Q1 FY2022Mar 31, 2022$15.64M+18.6%
Q4 FY2021Dec 31, 2021$13.66M+10.1%
Q3 FY2021Sep 30, 2021$13.37M+7.2%
Q2 FY2021Jun 30, 2021$14.23M+16.5%
Q1 FY2021Mar 31, 2021$13.19M+8.8%
Q4 FY2020Dec 31, 2020$12.40M–
Q3 FY2020Sep 30, 2020$12.48M–
Q2 FY2020Jun 30, 2020$12.22M–
Q1 FY2020Mar 31, 2020$12.12M–

More Vireo Growth figures

See a number that looks wrong?